{
    "clinical_study": {
        "@rank": "68749", 
        "arm_group": {
            "arm_group_label": "MBCT+SPI", 
            "arm_group_type": "Experimental", 
            "description": "Note: There is only one condition in this study. Mindfulness-Based Cognitive Therapy (MBCT) is combined with Safety Planning Intervention (SPI). All individuals who choose to participate will receive MBCT+SPI."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to combine and adapt Mindfulness-Based Cognitive Therapy (MBCT)\n      + Safety Planning Intervention (SPI) for individuals with suicidal behavior and to determine\n      its feasibility, acceptability, safety and preliminary effectiveness. An exploratory aim is\n      to collect data on the cognitive changes underlying treatment gains."
        }, 
        "brief_title": "Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Monopolar Depression, Single Episode or Unspecified", 
            "Suicidal and Self-injurious Behaviour"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Self-Injurious Behavior"
            ]
        }, 
        "detailed_description": {
            "textblock": "-  The study is a nine-week clinical trial combining Safety Planning Intervention plus\n           Mindfulness-Based Cognitive Therapy for patients with a recent history of suicidal\n           thoughts or behavior and current or past depressive symptoms.\n\n        -  These treatments work for depression and some preliminary data suggest they may work to\n           prevent suicidal behavior.\n\n        -  Participation includes:\n\n             -  Nine weeks of free treatment\n\n             -  Clinical assessments\n\n             -  An opportunity to offer your views on treatment and suggestions for      improving\n                the treatment in focus groups"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-65\n\n          -  History of depression\n\n          -  Suicidal behavior or thoughts (i.e., current suicidal thoughts at screening and\n             history of at least one suicide attempt or suicide-related behavior (aborted or\n             interrupted suicide attempt) or suicidal ideation with plan or method in the past 6\n             months)\n\n          -  In active treatment (e.g., receiving psychiatric medications)\n\n        Exclusion Criteria:\n\n          -  Current mania, psychosis, OCD, Traumatic Brain Damage, Organic or Acute Brain\n             Syndrome, Mental Retardation or pervasive developmental disorder\n\n          -  Requires priority treatment for an acute illness or debilitating problem such as\n             severe primary substance dependence or anorexia nervosa\n\n          -  Inability to complete psychiatric interview or group treatment due to lack of\n             cooperation or lack of comprehension."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01826240", 
            "org_study_id": "6592", 
            "secondary_id": "PDF-0-076-11"
        }, 
        "intervention": {
            "arm_group_label": "MBCT+SPI", 
            "description": "Safety Planning Intervention (SPI), a very brief intervention focused on identifying personalized coping strategies to manage acute suicidality, is combined with Mindfulness-Based Cognitive Therapy (MBCT), a group intervention comprised of mindfulness training and cognitive therapy techniques. Treatment lasts 9 weeks.", 
            "intervention_name": "MBCT+SPI", 
            "intervention_type": "Behavioral", 
            "other_name": [
                "Mindfulness-Based Cognitive Therapy", 
                "Safety Planning Intervention"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 3, 2013", 
        "location": {
            "contact": {
                "email": "mls2173@columbia.edu", 
                "last_name": "Megan Chesin, Ph.D.", 
                "phone": "212-543-6917"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10032"
                }, 
                "name": "Columbia University/New York State Psychiatric Institute"
            }, 
            "investigator": {
                "last_name": "Megan Chesin, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior: A Treatment Development Study", 
        "other_outcome": {
            "description": "neuropsychological tasks assessing attention and other cognitive processes", 
            "measure": "Change in cognitive processes underlying treatment gains", 
            "safety_issue": "No", 
            "time_frame": "baseline and post-treatment (at 9 weeks)"
        }, 
        "overall_contact": {
            "email": "mls2173@columbia.edu", 
            "last_name": "Megan Chesin, Ph.D.", 
            "phone": "212.543.6917"
        }, 
        "overall_official": {
            "affiliation": "Columbia University", 
            "last_name": "Megan Chesin, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Feasibility", 
                "measure": "Retention", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of treatment, an expected average of 9 weeks"
            }, 
            {
                "description": "Acceptability", 
                "measure": "Consumer Satisfaction Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "post-treatment (at 9 weeks)"
            }, 
            {
                "description": "Safety", 
                "measure": "Change in scores on Scale for Suicide Ideation", 
                "safety_issue": "Yes", 
                "time_frame": "participants will be followed for the duration of treatment, an expected average of 9 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01826240"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Effectiveness", 
            "measure": "Change in scores on Beck Depression Inventory (BDI-II)", 
            "safety_issue": "No", 
            "time_frame": "baseline and post-treatment (at 9 weeks)"
        }, 
        "source": "New York State Psychiatric Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "American Foundation for Suicide Prevention", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "New York State Psychiatric Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}